BioMarin Pharmaceutical Inc.

XTRA:BM8 Voorraadrapport

Marktkapitalisatie: €15.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

BioMarin Pharmaceutical Toekomstige groei

Future criteriumcontroles 4/6

BioMarin Pharmaceutical is forecast to grow earnings and revenue by 34% and 12.9% per annum respectively. EPS is expected to grow by 33.3% per annum. Return on equity is forecast to be 14.3% in 3 years.

Belangrijke informatie

34.0%

Groei van de winst

33.3%

Groei van de winst per aandeel

Biotechs winstgroei35.0%
Inkomstengroei12.9%
Toekomstig rendement op eigen vermogen14.3%
Dekking van analisten

Good

Laatst bijgewerkt20 Feb 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

XTRA:BM8 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20263,6937411,0291,30016
12/31/20253,28055882596924
12/31/20242,82334554466527
12/31/20232,40819040036427
9/30/20232,31114731139N/A
6/30/20232,23510041161N/A
3/31/20232,1737222147N/A
12/31/20222,09614244176N/A
9/30/20222,0088441180N/A
6/30/20221,91254-4119N/A
3/31/20221,8803924146N/A
12/31/20211,846-64185305N/A
9/30/20211,84916165280N/A
6/30/20211,917837155269N/A
3/31/20211,84479592214N/A
12/31/20201,860854-5285N/A
9/30/20201,86385275156N/A
6/30/20201,84712258140N/A
3/31/20201,805114388N/A
12/31/20191,704-24-9048N/A
9/30/20191,603-43-5940N/A
6/30/20191,533-110-11217N/A
3/31/20191,519-90-878N/A
12/31/20181,491-77-7420N/A
9/30/20181,496-125-12-15N/A
6/30/20181,439-125-14-23N/A
3/31/20181,383-145-629N/A
12/31/20171,314-117-83-9N/A
9/30/20171,255-156-234-24N/A
6/30/20171,201-181N/A-72N/A
3/31/20171,184-563N/A-137N/A
12/31/20161,117-630N/A-228N/A
9/30/20161,045-471N/A-293N/A
6/30/2016974-524N/A-286N/A
3/31/2016924-187N/A-253N/A
12/31/2015890-172N/A-219N/A
9/30/2015892-310N/A-179N/A
6/30/2015859-212N/A-185N/A
3/31/2015801-163N/A-183N/A
12/31/2014749-134N/A-70N/A
9/30/2014666-126N/A-58N/A
6/30/2014627-187N/A-59N/A
3/31/2014572-175N/A-54N/A
12/31/2013548-176N/A-57N/A
9/30/2013534-167N/A-36N/A
6/30/2013525-120N/A-13N/A
3/31/2013512-130N/A-7N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: BM8's forecast earnings growth (34% per year) is above the savings rate (0.6%).

Winst versus markt: BM8's earnings (34% per year) are forecast to grow faster than the German market (13% per year).

Hoge groeiwinsten: BM8's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: BM8's revenue (12.9% per year) is forecast to grow faster than the German market (4.8% per year).

Hoge groei-inkomsten: BM8's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: BM8's Return on Equity is forecast to be low in 3 years time (14.3%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y